Satoshi Muraoka

Satoshi Muraoka

Auto-generated profile, based on publicly available information

Satoshi Muraoka


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2020 in Cells
Verified
Journal Article
Open access
PDF file
SMSatoshi Muraoka
Satoshi Muraoka
MJMark P. Jedrychowski
Mark P. Jedrychowski
KYKiran Yanamandra
Kiran Yanamandra
SISeiko Ikezu
Seiko Ikezu
SGSteven P. Gygi
Steven P. Gygi
TITsuneya Ikezu
Tsuneya Ikezu
Pathological hallmarks of Alzheimer’s disease (AD) are deposits of amyloid beta (Aβ) and hyper-phosphorylated tau aggregates in brain plaques. Recent studies have highlighted the importance of Aβ and tau-containing extracellular vesicles (EVs) in AD. We therefore examined EVs separated from cerebrospinal fluid (CSF) of AD, mild cognitive impairment (MCI), and control (CTRL) patient samples to profile the protein composition of CSF EV. EV fractions were separated from AD (n = 13), MCI (n = 10), and CTRL (n = 10) CSF samples using MagCapture Exosome Isolation kit. The CSF-derived EV proteins were identified and quantified by label-free and tandem mass tag (TMT)-labeled mass spectrometry. Label-free proteomics analysis identified 2546 proteins that were significantly enriched for extracellular exosome ontology by Gene Ontology analysis. Canonical Pathway Analysis revealed glia-related signaling. Quantitative proteomics analysis, moreover, showed that EVs expressed 1284 unique proteins in AD, MCI and CTRL groups. Statistical analysis identified three proteins—HSPA1A, NPEPPS, and PTGFRN—involved in AD progression. In addition, the PTGFRN showed a moderate correlation with amyloid plaque (rho = 0.404, p = 0.027) and tangle scores (rho = 0.500, p = 0.005) in AD, MCI and CTRL. Based on the CSF EV proteomics, these data indicate that three proteins, HSPA1A, NPEPPS and PTGFRN, may be used to monitor the progression of MCI to AD.

5 February 2020 in Methods
Verified
Journal Article
Open access
SMSatoshi Muraoka
Satoshi Muraoka
WLWeiwei Lin
Weiwei Lin
MCMei Chen
Mei Chen
SHSamuel W. Hersh
Samuel W. Hersh
AEAndrew Emili
Andrew Emili
TITsuneya Ikezu
Tsuneya Ikezu
Extracellular vesicle (EV) is a unified terminology of membrane-enclosed vesicular species ubiquitously secreted by almost every cell type and present in all body fluids. They carry a cargo of lipids, metabolites, nucleic acids and proteins for their clearance from cells as well as for cell-to-cell communications. The exact composition of EVs and their specific functions are not well understood due to the underdevelopment of the separation protocols, especially those from the central nervous system including animal and human brain tissues as well as cerebrospinal fluids, and the low yield of proteins in the separated EVs. To understand their exact molecular composition and their functional roles, development of the reliable protocols for EV separation is necessary. Here we report the methods for EV separation from human and mouse unfixed frozen brain tissues by a sucrose step gradient ultracentrifugation method, and from human cerebrospinal fluids by an affinity capture method. The separated EVs were assessed for morphological, biophysical and proteomic properties of separated EVs by nanoparticle tracking analysis, transmission electron microscopy, and labeled and label-free mass spectrometry for protein profiling with step-by-step protocols for each assessment.

15 March 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ZRZhi Ruan
Zhi Ruan
DPDhruba Pathak
Dhruba Pathak
SKSrinidhi Venkatesan Kalavai
Srinidhi Venkatesan Kalavai
AYAsuka Yoshii-Kitahara
Asuka Yoshii-Kitahara
SMSatoshi Muraoka
Satoshi Muraoka
TITsuneya Ikezu
Tsuneya Ikezu
Extracellular vesicles (EVs) propagate tau pathology for Alzheimer’s disease (AD). How EV transmission influences AD are, nonetheless, poorly understood. To these ends, the physicochemical and molecular structure-function relationships of human brain-derived EVs, from AD and prodromal AD (pAD), were compared to non-demented controls (CTRL). AD EVs were shown to be significantly enriched in epitope-specific tau oligomers versus pAD or CTRL EVs assayed by dot-blot and atomic force microscopy tests. AD EVs were efficiently internalized by murine cortical neurons and transferred tau with higher aggregation potency than pAD and CTRL EVs. Strikingly, inoculation of tau-containing AD EVs into the outer molecular layer of the dentate gyrus induced tau propagation throughout the hippocampus. This was seen in 22 months-old C57BL/6 mice at 4.5 months post-injection by semiquantitative brain-wide immunohistochemistry tests with multiple anti-phospho-tau (p-tau) antibodies. Inoculation of the equal amount of tau from CTRL EVs or as oligomer or fibril-enriched fraction from the same AD donor showed little propagation. AD EVs induced tau accumulation in the hippocampus as oligomers or sarkosyl-insoluble proteins. Unexpectedly, p-tau cells were mostly GAD67 + GABAergic neurons and to a lesser extent, GluR2/3 + excitatory mossy cells, showing preferential EV-mediated GABAergic neuronal tau propagation. Whole-cell patch clamp recording of Cornu Ammonis (CA1) pyramidal cells showed significant reduction in the amplitude of spontaneous inhibitory post-synaptic currents. This was accompanied by reductions in c-fos + GAD67 + GABAergic neurons and GAD67 + GABAergic neuronal puncta surrounding pyramidal neurons in the CA1 region confirming reduced interneuronal projections. Our study posits a novel tau-associated pathological mechanism for brain-derived EVs.

6 November 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSatoshi Muraoka
Satoshi Muraoka
MJMark P. Jedrychowski
Mark P. Jedrychowski
NINaotoshi Iwahara
Naotoshi Iwahara
MAMohammad Abdullah
Mohammad Abdullah
KOKristen D. Onos
Kristen D. Onos
TITsuneya Ikezu
Tsuneya Ikezu
Extracellular vesicles (EVs) are secreted by any neuronal cells in the central nervous system (CNS) for molecular clearance, cellular communications and disease spread in multiple neurodegenerative diseases, including Alzheimer’s disease (AD), although their exact molecular mechanism is poorly understood. We hypothesize that high-resolution proteomic profiling of EVs separated from animal models of AD would determine the composition of EV contents and their cellular origin. Here, we examined recently developed transgenic mice (CAST. APP/PS1 ), which express familial AD-linked mutations of amyloid precursor protein ( APP ) and presenilin-1 ( PS1 ) in the CAST/EiJ mouse strain and develop hippocampal neurodegeneration. Quantitative proteomics analysis of EVs separated from CAST. APP/PS1 and age-matched control mice by tandem mass tag-mass spectrometry identified a total of 3,444 unique proteins, which are enriched in neuron, astrocyte, oligodendrocyte and microglia-specific molecules. CAST. APP/PS1 -derived EVs show significant enrichment of Psen1, APP, Itgax, and reduction of Wdr61, Pmpca, Aldh1a2, Calu, Anp32b, Actn4 and Ndufv2 compared to WT-derived EVs, suggesting the involvement of Aβ-processing complex and disease-associated / neurodegenerative microglia (DAM/MGnD) in EV secretion. In addition, Itgax and Apoe, the DAM/MGnD markers, in EV show a positive correlation with Itgax and Apoe mRNA expression from brain tissue in CAST. APP/PS1 mice. These datasets indicate the significant contribution of Aβ plaque and neurodegeneration-induced DAM/MGnD microglia for EV secretion in CAST. APP/PS1 mice and shed light on understanding the AD pathogenesis.

7 December 2020 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
SMSatoshi Muraoka
Satoshi Muraoka
MJMark P. Jedrychowski
Mark P. Jedrychowski
ZYZijian Yang
Zijian Yang
HTHarutsugu Tatebe
Harutsugu Tatebe
ADAnnina M. DeLeo
Annina M. DeLeo
TITsuneya Ikezu
Tsuneya Ikezu